Dissimilar patterns of degeneration in brain following four different addictive stimulants.
G Ellison, R C Switzer
Neuroreport October 25, 1993 DOI: 10.1097/00001756-199310000-00004 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal study Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | D-amphetamine cocaine phencyclidine methamphetamine |
| Duration | 5-day period for D-amphetamine, cocaine, and phencyclidine; high-dose but less prolonged regimen for methamphetamine |
| Key points | Drugs of abuse with psychotomimetic properties induce distinctively different patterns of neural degeneration, with D-amphetamine and cocaine affecting the fasciculus retroflexus, PCP affecting the posterior entorhinal cortex and related regions, and methamphetamine causing widespread damage. |
Abstract
Patterns of neural degeneration were compared following continuous administration of four drugs of addiction, each of which induces model psychoses in chronic addicts. D-amphetamine (D-Amph), cocaine (Coc), or phencyclidine (PCP) were administered continuously over a 5-day period. Both D-Amph and Coc induced pronounced degeneration in fasciculus retroflexus, but only D-Amph further induced substantial degeneration in striatum. Continuous PCP produced entirely different degeneration largely confined to the posterior entorhinal cortex, ventral dentate gyrus, and cingulate cortex. Methamphetamine (Meth) administered in the very high dose but less prolonged drug regimen often employed in studies of dopamine toxicity induced pronounced degeneration in striatum, but widespread degeneration in many other regions as well. These results indicate that drugs of abuse with psychotomimetic properties induce distinctively different patterns of neural degeneration, a finding with implications for theories of addiction and psychosis. They predict two different anatomical loci for alterations in psychosis: fasciculus retroflexus and ventral parahippocampus and hippocampus.
Citations in the library
Cited by 13
- Amphetamine toxicities Annals of the New York Academy of Sciences January 8, 2010
- A review of potential neuropathological changes associated with ketamine Expert Opinion on Drug Safety May 3, 2022
- Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression. Drugs March 1, 2017
- Phencyclidine rapidly decreases neuronal mRNA of brain-derived neurotrophic factor. Synapse June 2014
- A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology. Neuropsychopharmacology November 1, 2013
and 8 more in the library